Ignite Creation Date:
2024-05-05 @ 12:07 PM
Last Modification Date:
2024-10-26 @ 9:20 AM
Study NCT ID:
NCT00250861
Status:
TERMINATED
Last Update Posted:
2008-04-21
First Post:
2005-11-07
Brief Title:
Trial of Outpatient Immunotherapy With Rituximab and Aldesleukin IL-2 vs Rituximab Alone for Non-Hodgkins Lymphoma
Sponsor:
US Oncology Research
Organization:
US Oncology Research
Organization Data
Organization:
US Oncology Research
Class:
INDUSTRY
Study ID:
US-I-IL2-04-029
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
US Oncology Research
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Chiron Corporation | INDUSTRY |
| Fred Hutchinson Cancer Center | OTHER |